通过血脑屏障进行循环训练的基于模型的药理动力学控制
Síofra Ó Murdoch1, Eleonora M Aiello1,2, Francis J Doyle1,2
1Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Boston, MA 02134, USA.
International journal of molecular sciences
|October 14, 2023
概括
研究人员开发了模型,以了解药物如何穿越血脑屏障来改变昼夜节律. 这可能会导致对昼夜节律障碍的新疗法,如时差.
科学领域:
- 药理学 药理学是指药理学的学科.
- 时间生物学 时间生物学
- 神经科学是一个神经科学.
背景情况:
- 循环节相位转移提供了健康益处,但受到血脑屏障的限制.
- 神经学药物开发面临的挑战是由于分子吸收不良.
- 昼夜分子KL001显示了相位转移的潜力.
研究的目的:
- 在昼夜阶段动态上研究神经药物的药理动力学.
- 开发和验证大脑水平药物度的运输模型.
- 设计一个控制框架,用于昼夜阶段重置.
主要方法:
- 开发了五个经过验证的传输模型,用于口服药物.
- 设计了一个非线性模型预测控制 (MPC) 框架.
- 模拟的时差延迟场景来测试控制算法.
主要成果:
- 药物动力学模型准确地描述了药物度概况.
- 该MPC框架在模拟时差时实现了相位重置.
- 一个11小时的相位延迟需要4872小时的重置;一个5小时的提前需要3060小时.
结论:
- 这项研究提供了对昼夜系统的机制性见解.
- 这种方法增强了对治疗操纵可行性的理解.
- 开发的模型和框架支持对昼夜节律障碍的神经药物开发.
相关概念视频
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
69
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
69
Pharmacokinetic Models: Comparison and Selection Criterion
83
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
83
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
98
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
98
Model Approaches for Pharmacokinetic Data: Physiological Models
56
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
56
Pharmacokinetic Models: Overview
737
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
737
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
56
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
56


